Figures computed from official regulatory filings — .
Analysttarget 56 USD (+2013%) · consensus 5/5 · 1 buy · 0 hold · 0 sell
Ownershipinsiders 6.43% · institutions 7.79% · short 3.1% of float
In USD · as of Oct 26, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for Sunshine Biopharma Inc. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Market information source · Oct 26, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 26, 2026
Open-market timeline · full history
6 buys— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| NATAN DAVID | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| NATAN DAVID | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Slilaty Steve N. | Buy | $10K | conv 64 | SEC |
| Slilaty Steve N. | Buy | $2K | conv 98First in 12mo | SEC |
| Sebaaly Camille | Buy | $22.8K | conv 64 | SEC |
| Sebaaly Camille | Buy | $30.5K | conv 74First in 12mo | SEC |
| Slilaty Steve N. | Other | $99K | SEC |
| MERZOUKI ABDERRAZZAK | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Slilaty Steve N. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Sebaaly Camille | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Sebaaly Camille | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Sebaaly Camille | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Sebaaly Camille | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Sebaaly Camille | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MERZOUKI ABDERRAZZAK | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MERZOUKI ABDERRAZZAK | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Slilaty Steve N. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Slilaty Steve N. | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Slilaty Steve N. | Other | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Slilaty Steve N. | Award | $50K | SEC |
| MERZOUKI ABDERRAZZAK | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MERZOUKI ABDERRAZZAK | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MERZOUKI ABDERRAZZAK | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MERZOUKI ABDERRAZZAK | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MERZOUKI ABDERRAZZAK | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |